Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AdaptHealth stock | $25.26

Learn how to easily invest in AdaptHealth stock.

AdaptHealth Corp is a medical devices business based in the US. AdaptHealth shares (AHCO) are listed on the NASDAQ and all prices are listed in US Dollars. AdaptHealth employs 4,700 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in AdaptHealth

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AHCO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

AdaptHealth stock price (NASDAQ: AHCO)

Use our graph to track the performance of AHCO stocks over time.

AdaptHealth shares at a glance

Information last updated 2021-10-16.
Latest market close$25.26
52-week range$21.00 - $39.76
50-day moving average $23.87
200-day moving average $26.26
Wall St. target price$38.90
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.36

Buy AdaptHealth shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AdaptHealth stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AdaptHealth price performance over time

Historical closes compared with the close of $25.26 from 2021-10-15

1 week (2021-10-06) N/A
1 month (2021-09-17) 5.07%
3 months (2021-07-17) -6.62%
6 months (2021-04-16) -13.40%
1 year (2020-10-16) -10.23%
2 years (2019-10-17) 147.16%
3 years (2018-10-15) 159.88%
5 years (2016-10-13) N/A

Is AdaptHealth under- or over-valued?

Valuing AdaptHealth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AdaptHealth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AdaptHealth's EBITDA

AdaptHealth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $337.8 million.

The EBITDA is a measure of a AdaptHealth's overall financial performance and is widely used to measure a its profitability.

AdaptHealth financials

Revenue TTM $1.7 billion
Operating margin TTM 10.4%
Gross profit TTM $191.3 million
Return on assets TTM 4.15%
Return on equity TTM -8.06%
Profit margin -3.26%
Book value $14.53
Market capitalisation $3.3 billion

TTM: trailing 12 months

Shorting AdaptHealth shares

There are currently 4.7 million AdaptHealth shares held short by investors – that's known as AdaptHealth's "short interest". This figure is 4.2% down from 4.9 million last month.

There are a few different ways that this level of interest in shorting AdaptHealth shares can be evaluated.

AdaptHealth's "short interest ratio" (SIR)

AdaptHealth's "short interest ratio" (SIR) is the quantity of AdaptHealth shares currently shorted divided by the average quantity of AdaptHealth shares traded daily (recently around 708786.75799087). AdaptHealth's SIR currently stands at 6.57. In other words for every 100,000 AdaptHealth shares traded daily on the market, roughly 6570 shares are currently held short.

However AdaptHealth's short interest can also be evaluated against the total number of AdaptHealth shares, or, against the total number of tradable AdaptHealth shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AdaptHealth's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 AdaptHealth shares in existence, roughly 40 shares are currently held short) or 0.0635% of the tradable shares (for every 100,000 tradable AdaptHealth shares, roughly 64 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against AdaptHealth.

Find out more about how you can short AdaptHealth stock.

AdaptHealth share dividends

We're not expecting AdaptHealth to pay a dividend over the next 12 months.

AdaptHealth overview

AdaptHealth Corp. , together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania. .

Frequently asked questions

What percentage of AdaptHealth is owned by insiders or institutions?
Currently 27.655% of AdaptHealth shares are held by insiders and 58.301% by institutions.
How many people work for AdaptHealth?
Latest data suggests 4,700 work at AdaptHealth.
When does the fiscal year end for AdaptHealth?
AdaptHealth's fiscal year ends in December.
Where is AdaptHealth based?
AdaptHealth's address is: 220 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
What is AdaptHealth's ISIN number?
AdaptHealth's international securities identification number is: US00653Q1022
What is AdaptHealth's CUSIP number?
AdaptHealth's Committee on Uniform Securities Identification Procedures number is: 00653Q102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site